Publications by authors named "Angel Ramirez Payer"

Claim this Profile
O
Observational retrospective study of the treatment of Waldenström's macroglobulinemia with ibrutinib in routine clinical practice in Spain.
Carlos Fernández de Larrea, Javier Loscertales, Valentín Cabañas, Carmen Freiria, María Jesús Blanchard

Ther Adv Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction therapy with bortezomib, melphalan, and prednisone followed by lenalidomide and dexamethasone versus carfilzomib, lenalidomide, and dexamethasone with or without daratumumab in older, fit patients with newly diagnosed multiple myeloma (GEM-2017FIT): a phase 3, open-label, multicentre, randomised clinical trial.
María-Victoria Mateos, Bruno Paiva, M Teresa Cedena, Noemí Puig, Ana Maria Sureda-Balari, Angel Ramirez Payer

Lancet Haematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic subtyping by Whole Exome Sequencing across Diffuse Large B Cell Lymphoma and Plasmablastic Lymphoma.
Aitana Avendaño Pomares, Laura Rodríguez Merino, Sonia González, Jordi Morata, Raúl Tonda

PLoS One· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC study.
Lucía Pérez-Lamas, Raquel de Paz Arias, Rosa Mª Ayala Díaz, Luis Felipe Casado Montero, Ángel Ramírez Payer

Ann Hematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib in Combination with R-GemOx in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of Nongerminal Center B-cell-like Type: Phase II Clinical Trial of the Spanish GELTAMO Group.
Beatriz Rey-Búa, Carlos Grande, José J Sánchez Blanco, Pau Abrisqueta, Antonio Gutiérrez

Clin Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obinutuzumab plus bendamustine for relapsed/refractory chronic lymphocytic leukemia and predictive and prognostic impact of genetic alterations: the phase II GABRIELL study.
Julio Bravo, Patricia Baltasar Tello, Esther González Garcia, Eduardo Ríos Herranz, Angel Ramirez Páyer

Leuk Lymphoma· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study.
Javier de la Rubia, Bernardo González, Alfonso J Cruz-Jentoft, Lorena Iglesias, Isidro Jarque, Ángel Ramírez Payer

J Geriatr Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis.
Adrián Mosquera-Orgueira, Manuel Pérez-Encinas, Alberto Hernández-Sánchez, Teresa González-Martínez, Eduardo Arellano-Rodrigo, Angel Ramírez-Payer

Hemasphere· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis.
Juan-Carlos Hernández-Boluda, Irene Pastor-Galán, Eduardo Arellano-Rodrigo, José-María Raya, Manuel Pérez-Encinas, Angel Ramírez-Payer

Br J Haematol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-minimisation analysis of chronic lymphocytic leukemia in Spain in the era of oral targeted therapies.
Belén Montañés, Gema Casado, Ángeles Medina, Pablo Nieto, Ángel Ramírez-Payer

Farm Hosp· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study).
Pau Abrisqueta, Javier Loscertales, Maria José Terol, Ángel Ramírez Payer, Macarena Ortiz

Clin Lymphoma Myeloma Leuk· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma.
María José Cejalvo, Gabriela Bustamante, Esther González, Judith Vázquez-Álvarez, Ricarda García, Ángel Ramírez-Payer

Ann Hematol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis.
Isabel Cuenca, Daniel Alameda, Beatriz Sanchez-Vega, David Gomez-Sanchez, Diego Alignani, Angel Ramirez-Payer

Leukemia· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Prediction of Subsequent Molecular Response to Nilotinib in Patients with Chronic Myeloid Leukemia: Comparison of the Quantification of BCR-ABL1 Ratios Using ABL1 or GUSB Control Genes.
Ruth Stuckey, Luis-Felipe Casado, Dolors Colomer, María Teresa Gómez-Casares, Laura Casas, Ángel Ramírez-Payer

J Mol Diagn· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with daratumumab in patients with relapsed/refractory AL amyloidosis: a multicentric retrospective study and review of the literature.
Ramón Lecumberri, Isabel Krsnik, Elham Askari, Maialen Sirvent, Marta S González-Pérez, Ángel Ramírez-Payer

Amyloid· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patients.
Valentín García-Gutiérrez, Dragana Milojkovic, Juan Carlos Hernandez-Boluda, Simone Claudiani, María Luisa Martin Mateos, Ángel Ramírez Payer

Ann Hematol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase.
Juan Luis Steegmann, Dolors Colomer, Maria-Teresa Gómez-Casares, Valentín García-Gutiérrez, Guillermo Ortí, Angel Ramírez-Payer

J Cancer Res Clin Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase.
Juan Luis Steegmann, Dolors Colomer, Maria-Teresa Gómez-Casares, Valentín García-Gutiérrez, Guillermo Ortí, Angel Ramírez-Payer

J Cancer Res Clin Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Further psychometric validation of the GAH scale: Responsiveness and effect size.
Alfonso José Cruz-Jentoft, Bernardo González, Javier de la Rubia, José Ángel Hernández Rivas, Juan Alfonso Soler, Ángel Ramírez Payer

J Geriatr Oncol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update of the Grupo Español de Leucemia Linfocítica Crónica clinical guidelines of the management of chronic lymphocytic leukemia.
José A García-Marco, Julio Delgado, José A Hernández-Rivas, Ángel Ramírez Payer, Javier Loscertales Pueyo

Med Clin (Barc)· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum ferritin as prognostic marker in classical Hodgkin lymphoma treated with ABVD-based therapy.
Ruben Fernandez-Alvarez, Ana P Gonzalez-Rodriguez, M Esther Gonzalez, Arturo Rubio-Castro, Francisco Dominguez-Iglesias, Angel Ramirez Payer

Leuk Lymphoma· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib plus CHOP for the treatment of HIV-associated plasmablastic lymphoma: clinical experience in three patients.
Ruben Fernandez-Alvarez, Ana P Gonzalez-Rodriguez, Arturo Rubio-Castro, M Esther Gonzalez, Angel Ramirez Payer

Leuk Lymphoma· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis